Peroxiredoxin-2 links Cdk5 to neurodegeneration

Nature Medicine

Volumn 13, Issue 8, 2007, Pages 907-909

  Przedborski, Serge ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; PEROXIREDOXIN; PEROXIREDOXIN 2; PROTEIN P35; UNCLASSIFIED DRUG;

DISEASE MODEL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; NERVE CELL; NERVE DEGENERATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SHORT SURVEY;

CYCLIN-DEPENDENT KINASE 5; DOWN-REGULATION; HUMANS; NERVE DEGENERATION; PEROXIDASES; RISK FACTORS;

PARKINSONIA;

EID: 34547667122     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0807-907     Document Type: Short Survey

References (14)

1. Dauer, W. & Przedborski, S. Neuron 39, 889-909 (2003).
2. Nakamura, S., Kawamoto, Y., Nakano, S., Akiguchi, I. & Kimura, J. Acta Neuropathol. (Berl.) 94, 153-157 (1997).
3. Smith, P.D. et al. Proc. Natl. Acad. Sci. USA 100, 13650-13655 (2003).
4. Crocker, S.J. et al. J. Neurosci. 23, 4081-4091 (2003).
5. Smith, P.D. et al. J. Neurosci. 26, 440-447 (2006).
6. Qu, D. et al. Neuron 55, 37-52 (2007).
7. Dhavan, R. & Tsai, L.H. Nat. Rev. Mol. Cell Biol. 2, 749-759 (2001).
8. Patrick, G.N. et al. Nature 402, 615-622 (1999).
9. Kang, S.W., Rhee, S.G., Chang, T.S., Jeong, W. & Choi, M.H. Trends Mol. Med. 11, 571-578 (2005).
10. Rhee, S.G. Science 312, 1882-1883 (2006).
11. Perier, C. et al. Proc. Natl. Acad. Sci. USA 102, 19126-19131 (2005).
12. Perier, C. et al. Proc. Natl. Acad. Sci. USA 104, 8161-8166 (2007).
13. Canet-Aviles, R.M. et al. Proc. Natl. Acad. Sci. USA 101, 9103-9108 (2004).
14. DiMauro, S. & Schon, E.A. N. Engl. J. Med. 348, 2656-2668 (2003).